An observational study in Food Preferences and Obesity, sponsored by Lia Bally. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-05.
Sponsored by Lia Bally · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Obesity is currently one of the most substantial health burdens. Due to the production of marked and sustained weight loss, bariatric surgery is an increasingly used therapeutic modality to combat obesity and its comorbidities. Surgical rearrangement of the gastrointestinal tract remarkably alters metabolism and hormones acting on neurological and hypothalamic signalling, involved in food decision-making and eating behaviour. In this context, many patients who underwent bariatric surgery self-report changes in appetite, satiety and food preferences. Furthermore, new gut hormone-based (e.g. GLP-1 receptor agonist or GLP-1-RA) pharmacotherapies which mimic the effect of bariatric surgery show impressive efficacy on weight reduction by modulation of food behaviour. However, the mechanisms of such functional changes, and how they relate to food decision-making and food purchase behaviour remain unknown.
In Part 2 of the BrainFood-project, the investigators propose a novel approach using digital receipts from loyalty card to unravel the effect of obesity treatments (surgical and non-surgical) on eating and food purchase behaviour in daily life.
The overall aim of this project is to elucidate the changes in food behaviour among obese adults undergoing obesity treatments.
The main objective is to observe the effect of obesity treatments on food purchase behaviour using digital receipts from grocery shopping. The investigators hypothesize that bariatric surgery leads to changes in food purchase behaviour in obese adults.
The further objective is to compare food purchase behaviour between obese adults against values of an existing reference population, and to assess whether these differences tend to be reduced after the start of the treatment among obese participants.
155 studies on the registry are indexed under Food Preferences; 19 are open to participants now.
This study's enrollment of 61 is below the median of 80 across 34 observational studies indexed under Food Preferences.
Browse Food Preferences studies →Lia Bally is the lead sponsor of 15 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
A minimum of 60 (up to a maximum of 150) overweight/obese adults planned for or who started surgical or non-surgical obesity treatment within the past 6 months will be recruited for this study. Participants will be recruited by referral from our outpatient endocrine clinic and collaborating Centres of Excellence for Metabolic Surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
60 (minimum) to 150 (maximum) overweight/obese adults referred for or who started obesity (surgical or non-surgical) treatment within 6 months
Other: Questionnaire (Survey and Food Frequency Questionnaire (FFQ)) · Other: Collection of digital receipts from grocery shopping
Comparison of food purchase behaviour with control subjects will be performed using an already existing cohort from a previous study. This does not required recruiting control subjects.
Each participant will be asked to fill a web-based questionnaire that captures sociodemographic, lifestyle, physical and mental health information (Survey) and dietary intake patterns (FFQ). This will be done pre-treatment (only for those included pre-treatment), 6 months after the start of obesity treatment, 1 year after the start of the treatment and then yearly until 5 year after the start of the treatment.
Participants will create their BitsaboutMe-account (GDPR-compliant data sharing platform from Bern, Switzerland) with the help of study team members. Data from digital receipts will be obtained from Migros Cumulus and Coop Supercard via their BitsaboutMe-account. The data collection allow retrospective digital receipts collection for up to 2 years and automatically continuous collection during study duration. GDPR: General Data Protection Regulation
Changes in food purchase behaviour on the basis of the Healthy Trolley Index (HETI)
Changes in food purchase behaviour pre-treatment will be compared to post-treatment on the basis of the HETI, an objective and validated, nutrient-based, healthy shopping scoring system.
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in food purchase behaviour on the basis of the Grocery Purchase Quality Index (GPQI)
Changes in food purchase behaviour pre-treatment will be compared to post-treatment on the basis of the GPQI, an objective and validated, nutrient-based, healthy shopping scoring system.
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in food purchase behaviour on the basis of food groups
Changes in food purchase behaviour pre-treatment will be compared to post-treatment on the basis of food groups like vegetables, wholegrain, fruits, sweets and meats.
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in food purchase behaviour on the basis of nutrition facts
Changes in food purchase behaviour pre-treatment will be compared to post-treatment on the basis of nutrition facts like energy (kcal), carbohydrates, sugars, added sugars, protein, fat, saturated fat, dietary fibre and salt.
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in food purchase behaviour on the basis of the Nutri-Score
Changes in food purchase behaviour pre-treatment will be compared to post-treatment on the basis of the Nutri-Score, representing the nutritional quality of products. The Nutri-Score is based on a discrete continuous scale from -15 (most healthy) to 40 (least healthy). The score is then transcribed into five colour categories (A-E, ranging from bright green (most healthy) to red (least healthy)).
Time frame: Pre-treatment until 5 years after start of obesity treatment
Food purchase behaviour on the basis of the Healthy Trolley Index (HETI)
HETI will be compared between obesity treatment group and control group
Time frame: Pre-treatment until 5 years after start of obesity treatment
Food purchase behaviour on the basis of the Grocery Purchase Quality Index (GPQI)
GPQI will be compared between obesity treatment group and control group
Time frame: Pre-treatment until 5 years after start of obesity treatment
Food purchase behaviour on the basis of food groups
Food groups will be compared between obesity treatment group and control group
Time frame: Pre-treatment until 5 years after start of obesity treatment
Food purchase behaviour on the basis of nutrition facts
Nutrition facts will be compared between obesity treatment group and control group
Time frame: Pre-treatment until 5 years after start of obesity treatment
Food purchase behaviour on the basis of the Nutri-Score
Nutri-Score will be compared between obesity treatment group and control group
Time frame: Pre-treatment until 5 years after start of obesity treatment
Correlation between food purchase patterns (i.e. HETI, GPQI, food groups, nutrition facts, Nutri-Score) and self-perceived quality of life
Quality of life will be assessed using on a scale from 1 (very bad) to 5 (very good)
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in energy intake
Energy intake in kilocalories (kcal)/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily carbohydrate intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily sugar intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily fibre intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily protein intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily fat intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily saturated fat intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily sodium intake
Dietary intake in milligram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily vegetable intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily wholegrain intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily fruit intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily dessert intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Changes in daily meat intake
Dietary intake in gram/day based on Food Frequency Questionnaire
Time frame: Pre-treatment until 5 years after start of obesity treatment
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Nov 2021 to primary completion in Dec 2025, 49 months.
Of 13 observational studies under Food Preferences, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 43. This study's 49 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lia Bally